Severe Mental Illness: From Genetics to Translational Biology
This two-day symposium, chaired by Dr. Steve Hyman, Director of the Stanley Center for Psychiatric Research at the Broad Institute and Dr. Guoping Feng of McGovern Institute at MIT, and Director of the Neurobiology and Model Systems group of the Stanley Center, will bring together leading scientists working on the genetics and neurobiology of schizophrenia, bipolar disorder, autism and related neuropsychiatric disorders, with scientists working on translating these genetic findings to effective therapeutics for said diseases.
The illnesses highlighted in this symposium cause lifelong disability to millions of persons – combined, more than 3% of the world population are affected by one of these severe disorders. This is an exciting moment in the science, as results continue to emerge from large-scale genetics studies and continue to reveal shared and unshared risk factors across multiple disorders, and, more importantly, are beginning to coalesce around molecular mechanisms underlying these diseases. In the coming years neuroscientists will be increasingly able to put the emerging genetics to work in the service of new understandings of pathophysiology, the development of biomarkers, and much-needed new treatments. We hope, particularly, to attract graduate students and postdoctoral associates to this symposium in order to build this interdisciplinary field at a time of great opportunity.